ADR.AU · Adherium Limited

-

Please sign in to comment on ADR.AU

1 Comment

Admin

4 years, 10 months ago

Adherium Limited is currently in a long term downtrend where the price is trading 21.1% below its 200 day moving average.

From a valuation standpoint, the stock is 96.7% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 8.5.

Adherium Limited's total revenue sank by 82.2% to $253K since the same quarter in the previous year.

Its net income has dropped by 91.5% to $-9M since the same quarter in the previous year.

Finally, its free cash flow fell by 75.7% to $-3M since the same quarter in the previous year.

Based on the above factors, Adherium Limited gets an overall score of 1/5.

Sector
Industry
Exchange	AU
CurrencyCode	AUD
ISIN	AU000000ADR1

Beta	1.19
Market Cap	2M
PE Ratio	None
Target Price	0.0789
Dividend Yield	None

ABOUT

Adherium Limited

Adherium Limited, a digital health company, develops, manufactures, and supplies digital health technologies that address sub-optimal medication use in chronic diseases in New Zealand, Australia, Europe, and North America. The company offers Hailie Smartinhaler, a system for management of chronic respiratory conditions, including asthma and chronic obstructive pulmonary disease. It also provides Hailie Smartinhaler sensors; Hailie Solution; and Hailie Remote Patient Monitoring (RPM) Solution. The company was founded in 2001 and is based in Melbourne, Australia.

ADR.AU · Adherium Limited

-

Adherium Limited

Earnings

Valuation

Cash Flow

Profitability

Performance

Backtest Adherium Limited using a moving average strategy